Parecoxib sodium reduce fentanyl requirement after tonsillectomy in children

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-14004083

Enrollment

Unknown

Registered

2014-01-05

Start date

2013-12-09

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Tonsil hypertrophy

Interventions

Group P:Parecoxib sodium

Group S:0.9% NS

Eligibility

Sex/Gender

All

Age

3 Years to 7 Years

Inclusion criteria

Inclusion criteria: 60 children 3-7 years of age, classified as American Society of Anesthesiologists [ASA] physical status I-II, undergoing tonsillectomy during general anaesthesi.

Exclusion criteria

Exclusion criteria: Allergy to any of the medications used,severe cardiovascular disease, kidney or liver dysfunction, petic ulceration.

Design outcomes

Primary

Measure	Time frame
the number of patients receiving rescue fentany;Pain scores;	—

Contacts

Public ContactLi Xiuze

Department of Anesthesiology, Mianyang Central Hospital, Sichuan

lxz123@126.com+86 13881130420

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026